We are live on ! Find out more
MCM

Monimus Capital Management Portfolio holdings

AUM $361M
1-Year Est. Return 21.17%
This Fund
S&P 500
This Quarter Est. Return
-8.33%
1 Year Est. Return
+21.17%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$118M
AUM Growth
+$11.7M
Cap. Flow
+$23.9M
Cap. Flow %
20.32%
Top 10 Hldgs %
46.37%
Holding
66
New
15
Increased
18
Reduced
11
Closed
18

Top Buys

Rank Stock Value
1
DLTR icon
Dollar Tree
DLTR
+$7.75M
2
TRIP icon
TripAdvisor
TRIP
+$4.7M
3
MU icon
Micron Technology
MU
+$4.12M
4
FIVE icon
Five Below
FIVE
+$3.25M
5
PZZA icon
Papa John's
PZZA
+$3.05M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 42.17%
2 Industrials 14.38%
3 Consumer Staples 12.59%
4 Technology 12.46%
5 Communication Services 8.84%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BLDR icon
26
Builders FirstSource
BLDR
$8.04B
$1.84M 1.56%
+14,723
New +$2.14M
EVER icon
27
EverQuote
EVER
$906M
$1.8M 1.53%
68,861
-38,205
-36% -$875K
STRL icon
28
Sterling Infrastructure
STRL
$16.7B
$1.78M 1.51%
+15,693
New +$2.21M
TSVT
29
DELISTED
2seventy bio
TSVT
$1.46M 1.24%
296,260
+32,616
+12% +$104K
CPRI icon
30
Capri Holdings
CPRI
$1.74B
$1.43M 1.22%
72,647
-74,298
-51% -$1.65M
WINA icon
31
Winmark
WINA
$1.32B
$1.37M 1.16%
4,298
GPGI
32
GPGI Inc
GPGI
$4.35B
$1.18M 1%
108,164
-151,691
-58% -$1.86M
RSI icon
33
Rush Street Interactive
RSI
$2.88B
$1.05M 0.89%
97,686
+5,957
+6% +$78.3K
ORN icon
34
Orion Group Holdings
ORN
$418M
$980K 0.83%
187,401
+60,584
+48% +$424K
XPOF icon
35
Xponential Fitness
XPOF
$211M
$959K 0.81%
+115,170
New +$1.61M
KROS icon
36
Keros Therapeutics
KROS
$221M
$857K 0.73%
+84,055
New +$976K
BBIO icon
37
BridgeBio Pharma
BBIO
$16.5B
$821K 0.7%
23,760
-17,317
-42% -$584K
ARDX icon
38
Ardelyx
ARDX
$997M
$792K 0.67%
+161,227
New +$866K
ZUMZ icon
39
Zumiez
ZUMZ
$339M
$779K 0.66%
+52,300
New +$807K
RVLV icon
40
Revolve Group
RVLV
$1.73B
$772K 0.66%
35,938
+20,976
+140% +$583K
VKTX icon
41
Viking Therapeutics
VKTX
$4B
$547K 0.46%
22,643
+1,637
+8% +$51.7K
ASMB icon
42
Assembly Biosciences
ASMB
$529M
$402K 0.34%
42,067
LUXE
43
LuxExperience B.V.
LUXE
$1.11B
$342K 0.29%
+45,259
New +$419K
TECX
44
Tectonic Therapeutic
TECX
$606M
$327K 0.28%
+18,461
New +$602K
LRMR icon
45
Larimar Therapeutics
LRMR
$432M
$315K 0.27%
146,284
+99,184
+211% +$314K
CARG icon
46
CarGurus
CARG
$3.47B
$228K 0.19%
7,811
-2,092
-21% -$73.3K
SPRO icon
47
Spero Therapeutics
SPRO
$73M
$224K 0.19%
310,908
GPRO icon
48
GoPro
GPRO
$126M
$71K 0.06%
+107,166
New +$94.5K
AEO icon
49
American Eagle Outfitters
AEO
$3.01B
-60,079
Closed -$1M
AMZN icon
50
Amazon
AMZN
$2.96T
-2,788
Closed -$612K

Similar funds

Monimus Capital Management's Q1 2025 Portfolio in Review

As of Q1 2025, Monimus Capital Management held 66 positions worth $118M, up 11% from $106M the previous quarter. Its ten largest holdings account for 46% of the portfolio.

Monimus Capital Management deployed $23.9M of net new capital in Q1 2025, opening 15 new positions and adding to 18 existing holdings. Its largest new stake was TripAdvisor: 300,037 shares worth $4.25M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 42% of assets, down from 43% a quarter earlier, followed by Industrials and Consumer Staples.

On the sell side, the largest reduction was GPGI Inc, an estimated $1.86M trimmed.

  • Monimus Capital Management's largest Q1 2025 buy was TripAdvisor: 300,037 shares worth $4.25M.
  • Monimus Capital Management added most to Dollar Tree in Q1 2025, an estimated $7.75M increase.
  • Monimus Capital Management's biggest Q1 2025 reduction was GPGI Inc, cutting an estimated $1.86M.
  • Monimus Capital Management fully exited Endeavor Group Holdings, Inc. in Q1 2025, selling an estimated $5.18M.
  • Monimus Capital Management's ten largest holdings make up 46% of its $118M portfolio in Q1 2025.
  • Monimus Capital Management opened 15 new positions and closed 18 in Q1 2025.
  • Monimus Capital Management's portfolio value rose 11% quarter-over-quarter to $118M.

Based on Monimus Capital Management's 13F filing for Q1 2025, filed 15 May 2025.